DN Decision Briefs
Understand the conditions behind a platform claim. Follow the sources, see what remains unknown and save the exact evidence version you used.
Research directory
These are documentation reviews, not live execution tests or safety ratings. Review status is evaluated on 2026-10-14; it does not indicate live monitoring.
Compare account modes, collateral recognition, fee conditions and evidence gaps. Zero commission and shared balances do not establish total cost, withdrawal reliability or a safest-platform winner.
Within review window
Reviewed 2026-10-14 · v1.0.0
ApeX Omni separates funding from trading balances and supports cross collateral. API signing controls and withdrawal liquidity conditions deserve separate checks from a trading-fee headline.
Within review window
Reviewed 2026-10-14 · v1.0.0
SynFutures combines onchain orderbook and AMM liquidity for perpetuals. The reviewed tutorial distinguishes available balance, position margin and liquidity positions that can become trading exposure.
Within review window
Reviewed 2026-10-14 · v1.0.0
MUX is a suite, not one uniform execution venue. Aggregator routes can combine underlying protocols, while native V3 pools and leverage boosting introduce distinct collateral and cost conditions.
Within review window
Reviewed 2026-10-14 · v1.0.0
EVEDEX documentation separates USDT settlement, notional-based trading costs and activity-linked rewards. A cashback balance or wallet connection does not establish net cost or withdrawal reliability.
Within review window
Reviewed 2026-10-14 · v1.0.0
SAI documents gasless trading on Nibiru, but trading, trigger and rapid-close charges remain separate. Collateral and holding-time conditions are essential to any cost comparison.
Within review window
Reviewed 2026-10-14 · v1.0.0
GRVT distinguishes single-asset and multi-asset margin. USDC collateral support does not change USDT settlement, and a shortfall can introduce borrowing costs.
Within review window
Reviewed 2026-10-14 · v1.0.0
MYX V2 ties execution and fees to market conditions. Its documentation also describes rolling profit locks that can restrict withdrawals and use of profits in other markets.
Within review window
Reviewed 2026-10-14 · v1.0.0
Aster orderbook perpetuals distinguish cross, isolated and multi-asset margin. Shared collateral, negative balances and withdrawal constraints can matter more than a headline trading rate.
Within review window
Reviewed 2026-10-14 · v1.0.0
Collateral, shared margin and fee treatment depend on account mode and market. This brief separates unified accounts, portfolio margin and standard mode instead of treating every Hyperliquid balance alike.
Within review window
Reviewed 2026-10-14 · v1.0.0
Zero maker/taker fees apply to Standard accounts, while Plus and Premium use different terms. Margin mode is a separate choice, and non-USDC collateral introduces haircuts and liquidation exposure.
Within review window
Reviewed 2026-10-14 · v1.0.0
Paradex classifies orders as Retail or Pro by submission method. That affects fees and execution conditions, while the reviewed collateral guide requires USDC for perpetual trading.
Within review window
Reviewed 2026-10-14 · v1.0.0
Funding route, settlement chain and pool collateral are different decisions. This Arbitrum-focused GMX brief examines those boundaries, fee components, conditional exits and delegated trading permissions.
Within review window
Reviewed 2026-10-14 · v1.0.0
Collateral depends on the deployment. USDC has not universally replaced DAI. Check the selected network, collateral and full cost breakdown before considering a position.
Within review window
Reviewed 2026-10-14 · v1.0.0
Avantis now identifies as Veranta. Its current material describes USDC margin on Base and distinct fee models for RWA trading and Upside Perps. Neither a rebrand nor a zero-commission headline establishes total cost, safety or eligibility.
Within review window
Reviewed 2026-10-14 · v1.0.0
Compare the documented conditions, not an unsupported winner. Base is the shared deployment in this comparison; fee evidence is incomplete and no comparable live execution tests have been performed.
Within review window
Reviewed 2026-10-14 · v1.0.0
Provider statements link to their sources. Unknowns stay visible instead of becoming scores.
Network, collateral, product mode and cost assumptions matter. Incomplete evidence cannot support a cheapest-platform ranking.
Download the evidence or share a versioned link. A comparison receipt includes both underlying source snapshots.
